BIO-key International (BKYI) Projected to Post Earnings on Wednesday

BIO-key International (NASDAQ:BKYI) is expected to post its Q2 2026 results before the market opens on Wednesday, August 12th. Analysts expect the company to post earnings of ($0.82) per share and revenue of $1.80 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Friday, August 14, 2026 at 10:00 AM ET.

BIO-key International Stock Performance

Shares of NASDAQ:BKYI opened at $4.17 on Tuesday. The business has a fifty day moving average of $4.39 and a 200-day moving average of $5.30. BIO-key International has a twelve month low of $3.10 and a twelve month high of $19.70. The firm has a market cap of $4.55 million, a PE ratio of -0.75 and a beta of 0.44.

Institutional Trading of BIO-key International

An institutional investor recently raised its stake in BIO-key International stock. Geode Capital Management LLC boosted its position in BIO-key International Inc. (NASDAQ:BKYI) by 49.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 48,892 shares of the technology company’s stock after buying an additional 16,271 shares during the quarter. Geode Capital Management LLC owned approximately 0.45% of BIO-key International worth $26,000 as of its most recent filing with the SEC. 26.51% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on BKYI shares. Zacks Research raised shares of BIO-key International to a “hold” rating in a research note on Thursday, August 6th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a research note on Friday, July 17th. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, BIO-key International currently has an average rating of “Reduce”.

BIO-key International Company Profile

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.